Jacome M, Wu Q, Chen J, Mohamed Z, Mokhtari S, Pina Y
Int J Mol Sci. 2025; 26(5).
PMID: 40076927
PMC: 11900073.
DOI: 10.3390/ijms26052307.
Izadi N, Solar P, Hasanova K, Zamani A, Akbar M, Mrazova K
Fluids Barriers CNS. 2025; 22(1):3.
PMID: 39780275
PMC: 11708195.
DOI: 10.1186/s12987-025-00618-z.
Fan L, Lin Y, Fu Y, Wang J
Cancer Metastasis Rev. 2024; 44(1):5.
PMID: 39585433
DOI: 10.1007/s10555-024-10220-8.
Li T, Hao Q, Teng Z, Liu Y, Wu J, Zhang J
Clin Med Insights Oncol. 2024; 18:11795549241280506.
PMID: 39314798
PMC: 11418231.
DOI: 10.1177/11795549241280506.
Wang L, Zhai D, Tang L, Zhang H, Wang X, Ma N
Acta Biochim Biophys Sin (Shanghai). 2024; 56(9):1289-1299.
PMID: 39086352
PMC: 11532242.
DOI: 10.3724/abbs.2024084.
Identification and validation of a 4-extracellular matrix gene signature associated with prognosis and immune infiltration in lung adenocarcinoma.
Chai Y, Ma Y, Feng W, Xiang H, Lu H, Jin L
Heliyon. 2024; 10(2):e24162.
PMID: 38293522
PMC: 10827462.
DOI: 10.1016/j.heliyon.2024.e24162.
Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes.
Dankner M, Maritan S, Priego N, Kruck G, Nkili-Meyong A, Nadaf J
Neuro Oncol. 2024; 26(6):1052-1066.
PMID: 38271182
PMC: 11145453.
DOI: 10.1093/neuonc/noae013.
Identification of epithelial-mesenchymal transition-related biomarkers in lung adenocarcinoma using bioinformatics and lab experiments.
Cheng Y, Shen Y, Fang Q, Duan S, Wang Y, Dai X
Aging (Albany NY). 2023; 15(21):11970-11984.
PMID: 37910672
PMC: 10683598.
DOI: 10.18632/aging.205159.
The Role of Microglia in Brain Metastases: Mechanisms and Strategies.
Feng Y, Hu X, Zhang Y, Wang Y
Aging Dis. 2023; 15(1):169-185.
PMID: 37307835
PMC: 10796095.
DOI: 10.14336/AD.2023.0514.
Molecular Biology of Brain Metastases.
Gwak H
Brain Tumor Res Treat. 2023; 11(1):8-15.
PMID: 36762803
PMC: 9911708.
DOI: 10.14791/btrt.2022.0045.
HMMR potential as a diagnostic and prognostic biomarker of cancer-speculation based on a pan-cancer analysis.
Shang J, Zhang X, Hou G, Qi Y
Front Surg. 2023; 9:998598.
PMID: 36704516
PMC: 9873350.
DOI: 10.3389/fsurg.2022.998598.
Significance of macrophage infiltration in the prognosis of lung adenocarcinoma patients evaluated by scRNA and bulkRNA analysis.
Zhu H, Zheng C, Liu H, Kong F, Kong S, Chen F
Front Immunol. 2022; 13:1028440.
PMID: 36311801
PMC: 9597471.
DOI: 10.3389/fimmu.2022.1028440.
Recognition of driver genes with potential prognostic implications in lung adenocarcinoma based on H3K79me2.
Zhang L, Yang H, Liu J, Zhang L, Hao Y, Guo J
Comput Struct Biotechnol J. 2022; 20:5535-5546.
PMID: 36249560
PMC: 9556929.
DOI: 10.1016/j.csbj.2022.10.004.
CTpathway: a CrossTalk-based pathway enrichment analysis method for cancer research.
Liu H, Yuan M, Mitra R, Zhou X, Long M, Lei W
Genome Med. 2022; 14(1):118.
PMID: 36229842
PMC: 9563764.
DOI: 10.1186/s13073-022-01119-6.
Development and validation of an epithelial-mesenchymal transition-related gene signature for predicting prognosis.
Zhou D, Du Q, Fu Z, Wang X, Zhou L, Wang J
World J Clin Cases. 2022; 10(26):9285-9302.
PMID: 36159424
PMC: 9477694.
DOI: 10.12998/wjcc.v10.i26.9285.
Identifying General Tumor and Specific Lung Cancer Biomarkers by Transcriptomic Analysis.
Otalora-Otalora B, Osuna-Garzon D, Carvajal-Parra M, Canas A, Montecino M, Lopez-Kleine L
Biology (Basel). 2022; 11(7).
PMID: 36101460
PMC: 9313083.
DOI: 10.3390/biology11071082.
The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilities.
Hinneh J, Gillis J, Moore N, Butler L, Centenera M
Front Oncol. 2022; 12:982231.
PMID: 36033439
PMC: 9400171.
DOI: 10.3389/fonc.2022.982231.
A Novel Risk Score Model of Lactate Metabolism for Predicting over Survival and Immune Signature in Lung Adenocarcinoma.
Jiang Z, Luo Y, Zhang L, Li H, Pan C, Yang H
Cancers (Basel). 2022; 14(15).
PMID: 35954390
PMC: 9367335.
DOI: 10.3390/cancers14153727.
Comparison of tumor and two types of paratumoral tissues highlighted epigenetic regulation of transcription during field cancerization in non-small cell lung cancer.
Wang Q, Wu L, Yu J, Li G, Zhang P, Wang H
BMC Med Genomics. 2022; 15(1):66.
PMID: 35313869
PMC: 8939144.
DOI: 10.1186/s12920-022-01192-1.
A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer.
Zheng X, Zhou X, Xu H, Jin D, Yang L, Shen B
Front Genet. 2021; 12:764184.
PMID: 34899849
PMC: 8664435.
DOI: 10.3389/fgene.2021.764184.